Scholarlink

Objective <p>To validate the Iranian Brain Imaging Database (IBID) for dementia-free status in middle-aged to older adults (over 55&#xa0;years old) by comparing dementia probability metrics with Alzheimer’s disease (AD) patients from the Alzheimer’s Disease Neuroimaging Initiative (ADNI).</p> Methods <p>This cross-sectional study included 41 cognitively normal participants from IBID (age &gt; 55&#xa0;years; median (IQR) = 64 (62, 68) years; females = 51.2%) and 41 age/sex-matched AD patients from ADNI (age &gt; 55&#xa0;years; median (IQR) = 69 (62, 71) years; females = 53.7%). High-resolution 3D T1-weighted MPRAGE MRI data were harmonized across Siemens 3.0 Tesla scanners, preprocessed via the AssemblyNet-AD pipeline (volBrain), and analyzed for grading scores and hippocampal-amygdalo-ventricular atrophy scores (HAVAs), along with hippocampus, amygdala, and inferior lateral ventricle atrophy scores. Non-parametric Mann–Whitney U tests were used to compare group differences, and quantile regression (25th, 50th, and 75th quantiles) model atrophy severity-dependent associations.</p> Results <p>IBID participants exhibited minimal dementia probability (median grading score = 0.20% vs. ADNI = 99.93%; U = 84.0, <i>p</i> &lt; 0.0001) and markedly lower atrophy across all regions (HAVAs: 14.76 vs. 86.41; U = 75.0, <i>p</i> &lt; 0.0001), with non-overlapping interquartile ranges. Quantile regression revealed stable hippocampal contributions (q₀.₅ coefficient = 0.311, <i>p</i> &lt; 0.001) and increasing group disparities at higher atrophy severities (q₀.₇₅: IBID vs. ADNI coefficient = − 11.82, <i>p</i> &lt; 0.001).</p> Conclusion <p>We provided validated dementia-free IBID neuroimaging data to distinguish normal aging from dementia-AD status.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Validation of dementia-free status in the iranian brain imaging database using ADNI data: a transition point from middle age to older adulthood

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年7月10日

查看全文
  • Sadegh Ghaderi,
  • Sana Mohammadi,
  • Farzad Fatehi,
  • Minoo Sisakhti,
  • Seyed Amir Hossein Batouli

摘要

Objective

To validate the Iranian Brain Imaging Database (IBID) for dementia-free status in middle-aged to older adults (over 55 years old) by comparing dementia probability metrics with Alzheimer’s disease (AD) patients from the Alzheimer’s Disease Neuroimaging Initiative (ADNI).

Methods

This cross-sectional study included 41 cognitively normal participants from IBID (age > 55 years; median (IQR) = 64 (62, 68) years; females = 51.2%) and 41 age/sex-matched AD patients from ADNI (age > 55 years; median (IQR) = 69 (62, 71) years; females = 53.7%). High-resolution 3D T1-weighted MPRAGE MRI data were harmonized across Siemens 3.0 Tesla scanners, preprocessed via the AssemblyNet-AD pipeline (volBrain), and analyzed for grading scores and hippocampal-amygdalo-ventricular atrophy scores (HAVAs), along with hippocampus, amygdala, and inferior lateral ventricle atrophy scores. Non-parametric Mann–Whitney U tests were used to compare group differences, and quantile regression (25th, 50th, and 75th quantiles) model atrophy severity-dependent associations.

Results

IBID participants exhibited minimal dementia probability (median grading score = 0.20% vs. ADNI = 99.93%; U = 84.0, p < 0.0001) and markedly lower atrophy across all regions (HAVAs: 14.76 vs. 86.41; U = 75.0, p < 0.0001), with non-overlapping interquartile ranges. Quantile regression revealed stable hippocampal contributions (q₀.₅ coefficient = 0.311, p < 0.001) and increasing group disparities at higher atrophy severities (q₀.₇₅: IBID vs. ADNI coefficient = − 11.82, p < 0.001).

Conclusion

We provided validated dementia-free IBID neuroimaging data to distinguish normal aging from dementia-AD status.

Graphical Abstract